ANI Pharmaceuticals, ordinary share
US00182C1036, ANIP

Name: ANI Pharmaceuticals (ANIP) Stock Price Quote
Creator: Cbonds
License: https://creativecommons.org/licenses/by/4.0/

Add a stock to WL

Choose all Reset all

Save Close

ANI Pharmaceuticals, сountry — USA

No trading data

Data display in a chart | table

Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".

from

ADD-IN
Cbonds add-in API
bond data api

Authorization required

You need to request access

More than 2,500 records have been found, please specify your request

No data for the selected period

Latest quotes

explore the most comprehensive database

800 000

bonds globally

Over 400

pricing sources

80 000

stocks

9 000

ETF

track your portfolio in the most efficient way

Bond Search

Watchlist

Excel ADD-IN

Get access

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs

Get full access to the platform from any device & via Cbonds app

Enhance your portfolio management with Cbonds Excel Add-in

Build yield maps, make chart comparison within a click

Don't wait any longer — start using Cbonds today! Register

Issuer

Profile

ANI Pharmaceuticals, Inc., an integrated specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals. The company manufactures oral solid dose products, as well as liquids and topicals, narcotics, and potent products; and Lithobid lithium carbonate extended release tablets. Its targeted areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products.

Show more Hide

Issuer

ANI Pharmaceuticals
Full borrower / issuer name

ANI Pharmaceuticals, Inc.
Industry

Pharmaceutical Preparation and Biotechnology

Placement data

Placement type

SPO | Finished
Subscription type

Open
Placement exchange

NASDAQ
Ticker

ANIP
Placement

05.11.2021
Lock up period

180
Number of papers

1,500,000
Volume of raised funds

75 mln USD
Placement share

10.53%
Final placement price

50 USD
Price change since placement date

34.78%
By capitalization

712.04 mln USD

IFRS/US GAAP reports

2023
	I q eng
	II q eng
	III q eng
	IV q eng
2022
	I q eng
	II q eng
	III q eng
	IV q eng
2021
	I q eng
	II q eng
	III q eng
	IV q eng
2020
	I q eng
	II q eng
	III q eng
	IV q eng
2019
	I q eng
	II q eng
	III q eng
	IV q eng
2018
	I q eng
	II q eng
	III q eng
	IV q eng
2017
	I q eng
	II q eng
	III q eng
	IV q eng
2016
	I q eng
	II q eng
	III q eng
	IV q eng
2015
	I q eng
	II q eng
	III q eng
	IV q eng
2014



	IV q eng

Show all Hide

Authorization required

You need to request access

Related Stock indices

Indicators

News

17/04/2024	ANI Pharmaceuticals: Results Of Operations And Financial Condition, Regulation Fd Disclosure, Exhibits
12/03/2024	ANI Pharmaceuticals: Results Of Operations And Financial Condition, Regulation Fd Disclosure, Exhibits
29/02/2024	ANI Pharmaceuticals: Results Of Operations And Financial Condition, Exhibits
21/02/2024	Moody's Investors Service revised outlook on ANI Pharmaceuticals to positive and affirmed at "B2" (LT- foreign currency) credit rating
21/02/2024	Moody's revises ANI Pharmaceuticals' outlook to positive; affirms B2 CFR (Rating action commentary)

All organization news

ANI Pharmaceuticals, ordinary share
US00182C1036, ANIP

Stock information